SMTI — Sanara Medtech Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for Sanara Medtech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-4.45	-7.99	-8.09	-4.44	-9.91
Depreciation
Deferred Taxes
Non-Cash Items	1.3	3.76	5.49	0.7	5.67
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-1.18	-1.18	0.518	-3.18	-0.701
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	-4.03	-4.81	-5.55	-3.25	-0.024
Capital Expenditures	-1.64	-0.75	-0.747	-0.265	-0.229
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-1.1	-4.53	-2.76	-9.94	-6.38
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-2.74	-5.28	-3.51	-10.2	-6.61
Financing Cash Flow Items	0	-0.643	-0.627	-0.047	-2.22
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.622	28.3	-0.627	9.64	17.4
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-6.16	18.2	-9.69	-3.81	10.7